Using the ‘golden key’ to identify suitable patients, the results from the trial indicate that deaths could be cut by a third ...

The lead author said the study also showed the inavolisib-based therapy "more than doubled the time before their cancer progressed or worsened".

The lead author said the study also showed the inavolisib-based therapy "more than doubled the time before their cancer progressed or worsened".

A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests - ...

A “breakthrough” new three-drug combination offers hope for women battling an aggressive form of breast cancer, potentially ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

Although rarely used in the US, it may be time to revisit HRT for women with MS, as it eases overlapping symptoms and offers ...

Researchers analyzed over 15,000 postmenopausal Canadian women to investigate whether age at natural menopause influences the ...

The Women's Health Initiative — which houses its data center at Fred Hutch — is the largest women’s health study ever ...

What are the stakes when a fraction of a second, the length of an extended arm or the weight of a body in motion can mean the ...

After a few days, you start feeling the initial effects of living without that medication. Your brain gets foggy and you start dissociating. That is the gutting choice facing more than 275,000 ...